A risk prediction index for advanced colorectal neoplasia at screening colonoscopy

American Journal of Gastroenterology

Volumn 110, Issue 7, 2015, Pages 1062-1071

  Schroy, Paul C ^a   Wong, John B ^b   O'Brien, Michael J ^a   Chen, Clara A ^c   Griffith, John L ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASYMPTOMATIC DISEASE; BODY HEIGHT; BOOTSTRAPPING; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HIGH RISK POPULATION; HUMAN; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROBABILITY; RACE; RISK ASSESSMENT; SAFETY NET HOSPITAL; SCORING SYSTEM; SEX; SMOKING; ADVERSE EFFECTS; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MASS SCREENING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK; RISK FACTOR; STATISTICAL MODEL;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84936847496     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.146     Document Type: Article

References (57)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130-60.
3. US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-37.
4. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009 104: 739-50.
5. Qaseem A, Denberg TD, Hopkins RH Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012; 156: 378-86.
6. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use-United States, 2012. Morb Mortal Wkly Rep 2013; 62: 881-8.
7. Schroy PC III, Emmons K, Peters E, et al. The impact of a novel computerbased decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making 2011; 31: 93-107.
8. Hawley ST, McQueen A, Bartholomew LK, et al. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer 2011; 118: 2726-34.
9. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 2002; 12: 1-9.
10. Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol 2014; 12: 1624-34.
11. Schroy PC III, Coe A, Chen CA, et al. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med 2013; 159: 13-20.
12. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Cancer Causes Control 2000; 11: 477-88.
13. Kim DJ, Rockhill B, Colditz GA. Validation of the Harvard Cancer Risk Index: aprediction tool for individual cancer risk. J Clin Epidemiol 2004; 57: 332-40.
14. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University Schooof Medicine. Your Disease Risk. Available at: http://www. yourdiseaserisk.wustl.edu/ (last accessed on 23 May 2014).
15. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982; 35: 830-41.
16. O'Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-9.
17. Snover D, Ahnen D, Burt RW, et al. ed) Serrated polyps of the colon and rectum and serrated ("hyperplastic") polyposis. In: Bozman FT, Carneiro F, Hruban RH, Theise ND. WHO Classifi cation of Tumors Pathology of the Digestive System, 4th edn Springer: Berlin, Germany, 2010.
18. Levitzky BE, Brown CC, Heeren TC, et al. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population. Am J Gastroenterol 2011; 106: 1099-106.
19. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med 1998; 17: 1623-34.
20. Dempster A, Laird N, Rubin D. Maximum likelihood from incomplete data via the EM algorithm. J R Statist Soc Ser B 1977; 39: 1-38.
21. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999; 8: 3-15.
22. Lieberman DA, Williams JL, Holub JL, et al. Race, ethnicity, and sex affect risk for polyps greater than 9 mm in average-risk individuals. Gastroenterology 2014; 147: 351-8.
23. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifi cation and beyond. Stat Med 2008; 27: 157-72.
24. Leening MJ, Vedder MM, Witteman JC, et al. Net reclassifi cation improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med 2014; 160: 122-31.
25. Schroy PC III, Caron SE, Sherman BJ, et al. Risk assessment and clinical decision making for colorectal cancer screening. Health Expect 2014; doi: 10.111/hex.12110 (e-pub ahead of print).
26. Schroy PC III, Emmons KM, Peters E, et al. Aid-Assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med 2012; 43: 573-83.
27. Powell AA, Burgess DJ, Vernon SW, et al. Colorectal cancer screening mode preferences among U.S. veterans. Prev Med 2009; 49: 442-8.
28. Lebwohl B, Capiak K, Neugut AI, et al. Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy. Aliment Pharmacol Ther 2012; 35: 1467-73.
29. Friedenberg FK, Singh M, George NS, et al. Prevalence and distribution of adenomas in Black Americans undergoing colorectal cancer screening. Dig Dis Sci 2012; 57: 489-95.
30. Lieberman DA, Holub J, Eisen G, et al. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 2005; 3: 798-805.
31. Nguyen SP, Bent S, Chen YH, et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-Analysis. Clin Gastroenterol Hepatol 2009; 7: 676-81.
32. Bardou M, Montembault S, Giraud V, et al. Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study. Gut 2002; 50: 38-42.
33. Anderson JC, Alpern Z, Sethi G, et al. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 2005; 100: 2049-55.
34. Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-Analysis. Gastroenterology 2008; 134: 388-95.
35. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer, 2011. Available at: http://www.wcrf.org/PDFs/CUP-reports-SLRs/Colorectal-Cancer-2011-Report.pdf (last accessed on 23 May 2014).
36. Nimptsch K, Giovannucci E, Willett WC, et al. Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res (Phila) 2011; 4: 1710-8.
37. Laiyemo AO, Doubeni C, Pinsky PF, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 2010; 102: 538-46.
38. Zheng XE, Li T, Lipka S, et al. Location-dependent ethnic differences in the risk of colorectal adenoma: a retrospective multiethnic study. J Clin Gastroenterol 2014; 48: e1-7.
39. Howlader NNA, Krapcho M, Neyman N, et al. (Eds) SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations) National Cancer Institute: Bethesda, MD, Available at: http://seer.cancer.gov/csr/1975-2009-pops09/ (last accessed on 23 May 2014, based on November 2011 SEER data submission, posted to the SEER website, April 2012.
40. Khan O, Blanco A, Conrad P, et al. Performance of Lynch syndrome predictive models in a multi-center U.S. referral population. Am J Gastroenterol 2011; 106: 1822-7.
41. Kassirer JP, Pauker SG. The toss-up. N Engl J Med 1981; 305: 1467-9.
42. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 96-104.
43. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149: 659-69.
44. Steyerberg EW, Harrell FE Jr., Borsboom GJ, et al. Internal validation of predictive models: effi ciency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774-81.
45. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 2009; 27: 686-93.
46. Wells BJ, Kattan MW, Cooper GS, et al. Colorectal Cancer Predicted Risk Online (CRC-PRO) calculator using data from the multi-ethnic cohort study. J Am Board Fam Med 2014; 27: 42-55.
47. Schroy PC III, Coe AM, Mylvaganam SR, et al. The Your Disease Risk index for colorectal cancer is an inaccurate risk stratifi cation tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res 2012; 5: 1044-52.
48. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal fi ndings. N Engl J Med 2000; 343: 169-74.
49. Steffen A, MacInnis RJ, Joshy G, et al. Development and validation of a risk score predicting risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2014; 23: 2543-52.
50. Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol 2012; 175: 584-93.
51. Kaminski MF, Polkowski M, Kraszewska E, et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut 2014; 63: 1112-9.
52. Wong MC, Lam TY, Tsoi KK, et al. Predictors of advanced colorectal neoplasia for colorectal cancer screening. Am J Prev Med 2014; 46: 433-9.
53. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol 2014; 12: 478-85.
54. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 2005; 97: 715-23.
55. Doubeni CA, Major JM, Laiyemo AO, et al. Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst 2012; 104: 1353-62.
56. Shapiro JA, Klabunde CN, Thompson TD, et al. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012; 21: 895-904.
57. Hofstad B. Colon polyps: prevalence rates, incidence rates, and growth rates. In: Waye JDRD, Williams CB ed Colonoscopy: Principles and Practice, 2nd (edn). Blackwell Publishing: Oxford, UK, 2009, pp 358-78.